Literature DB >> 33757510

Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic.

Raúl Moreno1, José-Luis Díez2, José-Antonio Diarte3, Pablo Salinas4, José María de la Torre Hernández5, Juan F Andres-Cordón6, Ramiro Trillo7, Juan Alonso Briales8, Ignacio Amat-Santos9, Rafael Romaguera10, José-Francisco Díaz11, Beatriz Vaquerizo12, Soledad Ojeda13, Ignacio Cruz-González14, Daniel Morena-Salas15, Armando Pérez de Prado16, Fernando Sarnago17, Pilar Portero18, Alejandro Gutierrez-Barrios19, Fernando Alfonso20, Eduard Bosch21, Eduardo Pinar22, José-Ramón Ruiz-Arroyo23, Valeriano Ruiz-Quevedo24, Jesús Jiménez-Mazuecos25, Fernando Lozano26, José-Ramón Rumoroso27, Enrique Novo28, Francisco J Irazusta29, Bruno García Del Blanco30, José Moreu31, Sara M Ballesteros-Pradas32, Araceli Frutos33, Manuel Villa34, Eduardo Alegría-Barrero35,36, Rosa Lázaro37, Emilio Paredes38.   

Abstract

BACKGROUND: During COVID-19 pandemic, elective invasive cardiac procedures (ICP) have been frequently cancelled or postponed. Consequences may be more evident in patients with diabetes.
OBJECTIVES: The objective was to identify the peculiarities of patients with DM among those in whom ICP were cancelled or postponed due to the COVID-19 pandemic, as well as to identify subgroups in which the influence of DM has higher impact on the clinical outcome.
METHODS: We included 2,158 patients in whom an elective ICP was cancelled or postponed during COVID-19 pandemic in 37 hospitals in Spain. Among them, 700 (32.4%) were diabetics. Patients with and without diabetes were compared.
RESULTS: Patients with diabetes were older and had a higher prevalence of other cardiovascular risk factors, previous cardiovascular history and co-morbidities. Diabetics had a higher mortality (3.0% vs. 1.0%; p = 0.001) and cardiovascular mortality (1.9% vs. 0.4%; p = 0.001). Differences were especially important in patients with valvular heart disease (mortality 6.9% vs 1.7% [p < 0.001] and cardiovascular mortality 4.9% vs 0.9% [p = 0.002] in patients with and without diabetes, respectively). In the multivariable analysis, diabetes remained as an independent risk factor both for overall and cardiovascular mortality. No significant interaction was found with other clinical variables.
CONCLUSION: Among patients in whom an elective invasive cardiac procedure is cancelled or postponed during COVID-19 pandemic, mortality and cardiovascular mortality is higher in patients with diabetes, irrespectively on other clinical conditions. These procedures should not be cancelled in patients with diabetes.

Entities:  

Keywords:  COVID-19; Diabetes; Interventional cardiology; Mortality; Waiting list

Mesh:

Year:  2021        PMID: 33757510      PMCID: PMC7986134          DOI: 10.1186/s12933-021-01261-2

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  21 in total

1.  Prevalence and prediction of obstructive coronary artery disease in patients referred for valvular heart surgery.

Authors:  Jason M Lappé; Justin L Grodin; Yuping Wu; Corinne Bott-Silverman; Leslie Cho
Journal:  Am J Cardiol       Date:  2015-04-18       Impact factor: 2.778

2.  Causes of peri-operative mortality after transcatheter aortic valve implantation: a pooled analysis of 12 studies and 1223 patients.

Authors:  Raul Moreno; Luis Calvo; Pablo Salinas; David Dobarro; Jimenez Valero Santiago; Angel Sanchez-Recalde; Guillermo Galeote; Luis Riera; Isidro Moreno-Gomez; Jose Mesa; Ignacio Plaza; Jose Lopez-Sendon
Journal:  J Invasive Cardiol       Date:  2011-05       Impact factor: 2.022

3.  Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation.

Authors:  Jean-Pierre Bassand; Saverio Virdone; Samuel Z Goldhaber; A John Camm; David A Fitzmaurice; Keith A A Fox; Shinya Goto; Sylvia Haas; Werner Hacke; Gloria Kayani; Lorenzo G Mantovani; Frank Misselwitz; Karen S Pieper; Alexander G G Turpie; Martin van Eickels; Freek W A Verheugt; Ajay K Kakkar
Journal:  Circulation       Date:  2019-02-05       Impact factor: 29.690

4.  Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak.

Authors:  Raúl Moreno; José-Luis Díez; José-Antonio Diarte; Fernando Macaya; José-María de la Torrre Hernández; Oriol Rodríguez-Leor; Ramiro Trillo; Juan Alonso-Briales; Ignacio Amat-Santos; Rafael Romaguera; José-Francisco Díaz; Beatriz Vaquerizo; Soledad Ojeda; Ignacio Cruz-González; Daniel Morena-Salas; Armando Pérez de Prado; Fernando Sarnago; Pilar Portero; Alejandro Gutierrez-Barrios; Fernando Alfonso; Eduard Bosch; Eduardo Pinar; José-Ramón Ruiz-Arroyo; Valeriano Ruiz-Quevedo; Jesús Jiménez-Mazuecos; Fernando Lozano; José-Ramón Rumoroso; Enrique Novo; Francisco J Irazusta; Bruno García Del Blanco; José Moreu; Sara M Ballesteros-Pradas; Araceli Frutos; Manuel Villa; Eduardo Alegría-Barrero; Rosa Lázaro; Emilio Paredes
Journal:  Catheter Cardiovasc Interv       Date:  2020-12-17       Impact factor: 2.692

5.  [Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience].

Authors:  Oriol Rodríguez-Leor; Belén Cid-Álvarez; Armando Pérez de Prado; Xavier Rossello; Soledad Ojeda; Ana Serrador; Ramón López-Palop; Javier Martín-Moreiras; José Ramón Rumoroso; Ángel Cequier; Borja Ibáñez; Ignacio Cruz-González; Rafael Romaguera; Raúl Moreno; Manuel Villa; Rafael Ruíz-Salmerón; Francisco Molano; Carlos Sánchez; Erika Muñoz-García; Luís Íñigo; Juan Herrador; Antonio Gómez-Menchero; Antonio Gómez-Menchero; Juan Caballero; Soledad Ojeda; Mérida Cárdenas; Livia Gheorghe; Jesús Oneto; Francisco Morales; Félix Valencia; José Ramón Ruíz; José Antonio Diarte; Pablo Avanzas; Juan Rondán; Vicente Peral; Lucía Vera Pernasetti; Julio Hernández; Francisco Bosa; Pedro Luís Martín Lorenzo; Francisco Jiménez; José M de la Torre Hernández; Jesús Jiménez-Mazuecos; Fernando Lozano; José Moreu; Enrique Novo; Javier Robles; Javier Martín Moreiras; Felipe Fernández-Vázquez; Ignacio J Amat-Santos; Joan Antoni Gómez-Hospital; Joan García-Picart; Bruno García Del Blanco; Ander Regueiro; Xavier Carrillo-Suárez; Helena Tizón; Mohsen Mohandes; Juan Casanova; Víctor Agudelo-Montañez; Juan Francisco Muñoz; Juan Franco; Roberto Del Castillo; Pablo Salinas; Jaime Elizaga; Fernando Sarnago; Santiago Jiménez-Valero; Fernando Rivero; Juan Francisco Oteo; Eduardo Alegría-Barrero; Ángel Sánchez-Recalde; Valeriano Ruíz; Eduardo Pinar; Eduardo Pinar; Ana Planas; Bernabé López Ledesma; Alberto Berenguer; Agustín Fernández-Cisnal; Pablo Aguar; Francisco Pomar; Miguel Jerez; Francisco Torres; Ricardo García; Araceli Frutos; Juan Miguel Ruíz Nodar; Koldobika García; Roberto Sáez; Alfonso Torres; Miren Tellería; Mario Sadaba; José Ramón López Mínguez; Juan Carlos Rama Merchán; Javier Portales; Ramiro Trillo; Guillermo Aldama; Saleta Fernández; Melisa Santás; María Pilar Portero Pérez
Journal:  Rev Esp Cardiol       Date:  2020-10-09       Impact factor: 4.753

6.  Outcomes of Patients With Asymptomatic Aortic Stenosis Followed Up in Heart Valve Clinics.

Authors:  Patrizio Lancellotti; Julien Magne; Raluca Dulgheru; Marie-Annick Clavel; Erwan Donal; Mani A Vannan; John Chambers; Raphael Rosenhek; Gilbert Habib; Guy Lloyd; Stefano Nistri; Madalina Garbi; Stella Marchetta; Khalil Fattouch; Augustin Coisne; David Montaigne; Thomas Modine; Laurent Davin; Olivier Gach; Marc Radermecker; Shizhen Liu; Linda Gillam; Andrea Rossi; Elena Galli; Federica Ilardi; Lionel Tastet; Romain Capoulade; Robert Zilberszac; E Mara Vollema; Victoria Delgado; Bernard Cosyns; Stephane Lafitte; Anne Bernard; Luc A Pierard; Jeroen J Bax; Philippe Pibarot; Cécile Oury
Journal:  JAMA Cardiol       Date:  2018-11-01       Impact factor: 14.676

7.  Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography.

Authors:  Zhi-gang Chu; Zhi-gang Yang; Zhi-hui Dong; Zhi-yu Zhu; Li-qing Peng; Heng Shao; Ci He; Wen Deng; Si-shi Tang; Jing Chen
Journal:  Cardiovasc Diabetol       Date:  2010-11-10       Impact factor: 9.951

8.  Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Alaide Chieffo; Giuseppe Tarantini; Christoph Kurt Naber; Emanuele Barbato; Marco Roffi; Giulio G Stefanini; Gill Louise Buchanan; Piotr Buszman; Raúl Moreno; Barbara Zawiślak; Guillaume Cayla; Haim Danenberg; Joao Antonio Brum Da Silveira; Holger Nef; Stefan K James; Josepa Mauri Ferre; Michiel Voskuil; Nils Witt; Stephan Windecker; Andreas Baumbach; Dariusz Dudek
Journal:  EuroIntervention       Date:  2021-02-19       Impact factor: 6.534

9.  Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease.

Authors:  Charlotte Andersson; Gunnar H Gislason; Peter Weeke; Søren Hoffmann; Peter R Hansen; Christian Torp-Pedersen; Peter Søgaard
Journal:  Cardiovasc Diabetol       Date:  2010-01-18       Impact factor: 9.951

10.  Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-09-07       Impact factor: 9.951

View more
  1 in total

1.  Spanish Cardiac Catheterization and Coronary Intervention Registry. 30th Official Report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2020) in the year of the COVID-19 pandemic.

Authors:  Rafael Romaguera; Soledad Ojeda; Ignacio Cruz-González; Raúl Moreno
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2021-10-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.